No evidence of correlation between mutation at codon 531 of src and the risk of colon cancer in Chinese

被引:35
作者
Wang, NM
Yeh, KT
Tsai, CH
Chen, SJ
Chang, JG [1 ]
机构
[1] China Med Coll Hosp, Dept Med Res, Div Mol Med, Taichung, Taiwan
[2] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan
关键词
src; colon cancer; polymerase chain reaction; proto-oncogene protein pp60(c-src); Chinese;
D O I
10.1016/S0304-3835(99)00398-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The protein tyrosine kinase activity of c-src proto-oncogene product, pp60(c-src), is elevated in a number of human cancers, including colon cancer. Phosphorylation of human pp60(c-src) carboxy-terminal tyrosine 530 suppresses its kinase activity. A recent report suggested that the risk of colon cancer is higher for those who carry a C --> T transition mutation on codon 531 (Gln-531 --> Amber-531) of src gene. This mutation caused a prematured translation termination and up-regulated the kinase activity. To examine whether this mutation could be a risk factor for colon carcinoma in the Chinese population, we used the same PCR-based assay to analyze src genotypes of 131 colon cancers and other various types of carcinoma. No mutation was detected in all specimens that were screened in this study. Thus, mutation at Gln-531 of src gene does not seem to be involved in the development of colon cancer in Chinese ethnicity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 19 条
  • [1] BOLEN JB, 1993, ONCOGENE, V8, P2025
  • [2] TYR527 IS PHOSPHORYLATED IN PP60C-SRC - IMPLICATIONS FOR REGULATION
    COOPER, JA
    GOULD, KL
    CARTWRIGHT, CA
    HUNTER, T
    [J]. SCIENCE, 1986, 231 (4744) : 1431 - 1434
  • [3] DEPHOSPHORYLATION OR ANTIBODY-BINDING TO THE CARBOXY TERMINUS STIMULATES PP60C-SRC
    COOPER, JA
    KING, CS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (12) : 4467 - 4477
  • [4] ACTIVATION OF THE PP60C-SRC KINASE BY MIDDLE ANTIGEN-T BINDING OR BY DEPHOSPHORYLATION
    COURTNEIDGE, SA
    [J]. EMBO JOURNAL, 1985, 4 (06) : 1471 - 1477
  • [5] Activating SRC mutation in a subset of advanced human colon cancers
    Irby, RB
    Mao, WG
    Coppola, D
    Kang, J
    Loubeau, JM
    Trudeau, W
    Karl, R
    Fujita, DJ
    Jove, R
    Yeatman, TJ
    [J]. NATURE GENETICS, 1999, 21 (02) : 187 - 190
  • [6] JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31
  • [7] KMIECK TE, 1987, CELL, V49, P75
  • [8] Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma
    Masaki, T
    Okada, M
    Tokuda, M
    Shiratori, Y
    Hatase, O
    Shirai, M
    Nishioka, M
    Omata, M
    [J]. HEPATOLOGY, 1999, 29 (02) : 379 - 384
  • [9] OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773
  • [10] PARK J, 1995, MOL CELL BIOL, V15, P2374